
Academic Journal
Q1Nature reviews. Rheumatology
About Nature reviews. Rheumatology
Nature reviews. Rheumatology is a scholarly journal published by Nature Research. SCImago 2025 places it in Q1 with an SJR of 6.768 and an H-index of 214.
Its listed coverage is 2009-2026 and its research categories include Rheumatology (Q1). The 2025 dataset reports 129 documents and 5340 citations across the latest three-year reporting window.
Nature Reviews Rheumatology: Leading the Conversation in Rheumatic Disease Research
Nature Reviews Rheumatology is a premier peer-reviewed journal that serves as a trusted resource for clinicians, researchers, and healthcare professionals involved in rheumatology. As part of the globally respected Nature Reviews series, the journal is renowned for delivering high-quality, authoritative, and accessible content that shapes the future of rheumatic disease care and research.
A Trusted Source for the Latest in Rheumatology
Published by Springer Nature, Nature Reviews Rheumatology offers in-depth reviews and perspectives on a wide range of topics, including autoimmune diseases, osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, gout, and vasculitis. The journal is a vital platform for understanding the pathophysiology, diagnosis, and treatment of musculoskeletal and autoimmune conditions. With its rigorous editorial standards and contributions from international experts, the journal is a go-to source for the most up-to-date and clinically relevant information in the field.
Key Features and Content Types
One of the key strengths of Nature Reviews Rheumatology is its variety of content formats. The journal features:
-
Review Articles: Comprehensive, evidence-based summaries of current research topics.
-
Perspectives and Commentaries: Expert insights into ongoing debates and emerging trends.
-
Research Highlights: Summaries of significant studies from other high-impact journals.
-
News & Views: Brief reports on groundbreaking developments in rheumatology.
These features ensure that readers are kept informed about the latest scientific discoveries, clinical trials, treatment strategies, and technological advancements impacting rheumatology practice worldwide.
Global Reach and High Impact Factor
Nature Reviews Rheumatology boasts a high impact factor, consistently ranking among the top journals in the field of rheumatology. This reflects the journal's wide readership, significant citation rate, and its role in shaping clinical practice and research direction. With a global audience spanning academic institutions, hospitals, and research centers, the journal plays a critical role in knowledge dissemination.
Why Nature Reviews Rheumatology Matters
In an era of rapid medical advancements, staying current with the latest evidence-based practices is essential. Nature Reviews Rheumatology provides a reliable and comprehensive overview of complex topics, helping clinicians make informed decisions and researchers identify knowledge gaps. It also highlights patient-centered approaches, multidisciplinary care strategies, and the role of precision medicine in rheumatology.
Moreover, by addressing both established and emerging areas of interest — such as the microbiome, immunotherapy, and digital health in rheumatology — the journal fosters innovation and collaboration across specialties.
Subscribe and Stay Updated
Whether you're a practicing rheumatologist, a researcher exploring immunological mechanisms, or a medical student interested in autoimmune diseases, Nature Reviews Rheumatology offers valuable insights to support your work. Subscribing to the journal ensures access to cutting-edge reviews and expert perspectives, enabling professionals to remain at the forefront of rheumatologic care.
Meta Description (SEO Tip):
Stay updated with Nature Reviews Rheumatology, a leading peer-reviewed journal offering expert insights and reviews on autoimmune and musculoskeletal diseases. Learn more today.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Understanding the Scope of Nature Reviews Rheumatology
Nature Reviews Rheumatology is one of the most respected and widely-read journals in the field of rheumatology. As part of the prestigious Nature Portfolio, the journal provides high-impact, peer-reviewed content that synthesizes the latest advancements in rheumatology research and clinical practice. The scope of Nature Reviews Rheumatology is broad yet meticulously curated, ensuring relevance for clinicians, researchers, and healthcare professionals alike.
Core Focus Areas
The primary aim of Nature Reviews Rheumatology is to deliver authoritative and accessible reviews across the entire spectrum of rheumatic diseases. These include:
-
Inflammatory and autoimmune disorders such as rheumatoid arthritis, lupus, spondyloarthritis, and vasculitis.
-
Degenerative conditions including osteoarthritis and related musculoskeletal disorders.
-
Rare and systemic diseases such as systemic sclerosis, myositis, and autoinflammatory syndromes.
-
Pediatric rheumatology, addressing juvenile idiopathic arthritis and other childhood-onset conditions.
Beyond disease-specific topics, the journal also explores cross-cutting issues such as immunopathogenesis, biomarkers, genetics, precision medicine, epidemiology, and translational research.
Interdisciplinary Approach
What sets Nature Reviews Rheumatology apart is its interdisciplinary outlook. The journal often intersects with fields such as immunology, internal medicine, orthopedics, dermatology, and nephrology—making it a valuable resource not just for rheumatologists, but for a broader scientific and medical audience.
The publication also emphasizes developments in:
-
Therapeutics: Biologics, small-molecule drugs, and emerging treatment modalities.
-
Diagnostics: Advances in imaging techniques and laboratory testing.
-
Patient care: Best practices in disease management, rehabilitation, and patient education.
High-Quality Reviews and Expert Opinions
Unlike traditional research journals, Nature Reviews Rheumatology focuses on publishing high-quality narrative reviews, editorials, and commentaries written by experts in the field. These articles are designed to offer a critical synthesis of the latest research, highlight emerging trends, and provide clinical guidance grounded in evidence-based medicine.
Global Relevance and Impact
The journal maintains a strong international reputation, with contributions from leading researchers and clinicians around the world. It serves as an essential educational tool for continuing medical education (CME) and for keeping up to date with the fast-evolving landscape of rheumatology.
According to the latest Journal Citation Reports, Nature Reviews Rheumatology consistently ranks among the top journals in rheumatology based on impact factor and citation metrics. This reinforces its role as a trusted source of information in both academic and clinical settings.
Final Thoughts
Whether you are a rheumatologist, researcher, or healthcare professional, understanding the scope of Nature Reviews Rheumatology can help you leverage this resource for ongoing education, clinical insights, and scientific discovery. With its commitment to excellence, clarity, and clinical relevance, the journal continues to shape the future of rheumatology worldwide.
Recent Research Articles
Latest publications matched automatically by ISSN.
Macrophages in fibrin-rich lining niche shape the rheumatoid pannus
Mariola Kurowska-Stolarska, Stefano Alivernini
2026-09-07 · DOI: 10.1038/s41584-026-01428-9Antibiotic-induced loss of gut SCFAs exacerbates alphavirus arthritis
Holly Webster
2026-09-04 · DOI: 10.1038/s41584-026-01435-wMitochondrial succinate sensing promotes macrophage inflammation in RA
Jessica McHugh
2026-09-03 · DOI: 10.1038/s41584-026-01434-xVaccination considerations in autoimmune rheumatic diseases
Meliha C. Kapetanovic
2026-09-03 · DOI: 10.1038/s41584-026-01427-wCDC42–pyrin interactions promote inflammasome activation and autoinflammatory disease
Holly Webster
2026-09-02 · DOI: 10.1038/s41584-026-01433-yADAR1 variants define an interferon-related subtype of psoriatic disease
Holly Webster
2026-09-01 · DOI: 10.1038/s41584-026-01431-0Time to rethink clinical trial design in Sjögren disease
Raphaèle Seror, Xavier Mariette
2026-09-01 · DOI: 10.1038/s41584-026-01429-8Air pollution worsens disease activity in RA
Jessica McHugh
2026-08-27 · DOI: 10.1038/s41584-026-01432-zHepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases
Andras Perl, Katalin Banki
2026-08-26 · DOI: 10.1038/s41584-026-01421-2Author Correction: Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis
Zoltán Szekanecz, Lilla Gunkl-Tóth, Szilvia Szamosi, Diane van der Woude et al.
2026-08-24 · DOI: 10.1038/s41584-026-01430-1Towards a global collaborative approach to living guideline development in rheumatology
Laurent Arnaud, Guillermo J. Pons-Estel
2026-08-24 · DOI: 10.1038/s41584-026-01422-1Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis
Alexandra Audemard-Verger, Evangéline Pillebout, Eva Baier, Ingeborg M. Bajema et al.
2026-08-20 · DOI: 10.1038/s41584-026-01420-3TYK2 inhibition shows durable efficacy in PsA
Jessica McHugh
2026-08-17 · DOI: 10.1038/s41584-026-01426-xSmart contact lenses enable personalized uric acid monitoring
Jessica McHugh
2026-08-17 · DOI: 10.1038/s41584-026-01424-zKeeping gout on target with nurse-supported urate self-monitoring
Ana Beatriz Vargas-Santos, Rosa Weiss Telles
2026-08-13 · DOI: 10.1038/s41584-026-01419-wTime for a disease-specific approach to lymphoma in Sjögren disease
Gaetane Nocturne, Marguerite Vignon
2026-08-12 · DOI: 10.1038/s41584-026-01425-yAdopting treat-to-target in paediatric rheumatic diseases
Alessandro Consolaro, Angelo Ravelli
2026-08-11 · DOI: 10.1038/s41584-026-01423-0Advances in the treatment of eosinophilic granulomatosis with polyangiitis
Adrien Cottu, Florence Roufosse, Allyson Egan, Giacomo Emmi et al.
2026-09 · DOI: 10.1038/s41584-026-01406-1Navigating evidence-based recommendations for the management of systemic sclerosis
Francesco Del Galdo, Yannick Allanore, Oliver Distler, Anna Maria Hoffmann-Vold et al.
2026-08-04 · DOI: 10.1038/s41584-026-01416-zMetabolic exhaustion and immune ageing in rheumatoid arthritis
Cornelia M. Weyand, Jörg J. Goronzy
2026-09 · DOI: 10.1038/s41584-026-01402-5Reviews
Community Reviews
Version History
April 20, 2025 at 12:29 pm
April 20, 2025